上集講述了PD1/PDL1在醫治癌細胞免疫治療方面的重要性,接下來我們將會繼續深入探討問題。1141Please respect copyright.PENANA2D7qu34buf
1141Please respect copyright.PENANAaqWpsaE2cs
上集:https://www.penana.com/article/4711251141Please respect copyright.PENANACKnsn5qjkH
1141Please respect copyright.PENANAyMKVvq0eQ1
1141Please respect copyright.PENANAXNQrocaC3R
1141Please respect copyright.PENANAeJ0TiLUcL4
(圖1)雖然阻擋PD1/PDL1可以增強T cell辨認癌細胞的能力,但另一個重要的問題是,如何確保有足夠的T cell殺滅癌細胞呢?1141Please respect copyright.PENANAnSW2EVIaqD
1141Please respect copyright.PENANAmSf3YOlUAi
就算成功糾正免疫系統細胞懂得把癌細胞辨認為外來之物,但免疫系統細胞數量不足的話,依然是不會達到重大效果的。1141Please respect copyright.PENANAw97lUckqB4
1141Please respect copyright.PENANAwKpi5RLe5l
換句話說,我們需要一道能夠提升針對癌細胞的T cell數量手段。1141Please respect copyright.PENANAqIDwhI5vQV
1141Please respect copyright.PENANAcqy8rvwZoG
1141Please respect copyright.PENANAdj0EQ5QeI1
1141Please respect copyright.PENANAWf4YE8QrVq
(圖2)T cell的產生數量,接近可以說是由Antigen Presenting Cells(APC)來決定;1141Please respect copyright.PENANAM1o9cE1IzB
APC可以睇成為一堆負責把癌細胞獨特Neoantigen帶來T cell面前的細胞。1141Please respect copyright.PENANA3v4VPfzGfm
1141Please respect copyright.PENANAa3uojImOuR
忘記甚麼是Neoantigen的話,可重溫上一集。1141Please respect copyright.PENANAk9NAt3HdT0
1141Please respect copyright.PENANAPPOFVutE7m
當APC展示癌細胞的Neoantigen予T cell的receptor後,另一個必需的動作就是T cell表面的CD28與APC表面的B7合併。1141Please respect copyright.PENANA5YelXeiTx1
1141Please respect copyright.PENANAdHDXEl4Gtp
只要兩者條件達成的話,負責對付對應癌細胞的T cell數量及效力便會大增。1141Please respect copyright.PENANAOviRtRdrio
1141Please respect copyright.PENANAXG1LsOuDRR
1141Please respect copyright.PENANAecmjCqqrJQ
1141Please respect copyright.PENANAzW0qDNJ4mu
(圖3)然而,當T cell數量產生至一定程度的時候,T cell便會產生出CTLA4。CTLA4會搶奪CD28的位置,與B7合併。1141Please respect copyright.PENANAFiaZrGqGNh
1141Please respect copyright.PENANAcm5LseG7Rk
而當CTLA4與B7合併後,T cell所產生的數量及威力就會大減。1141Please respect copyright.PENANAauEYborp8u
1141Please respect copyright.PENANAWDez10Zrmj
這個CTLA4產生的機制是與生俱來的,目的就是為了避免產生過量的T cell,以免身體會產生不良反應。1141Please respect copyright.PENANAP5PTp3EZUJ
1141Please respect copyright.PENANAZbUxcaIZGc
1141Please respect copyright.PENANAKuMxn89wgQ
(圖4)只不過的是,現時癌細胞大敵當前,燃眉之急就是要調動大量的T cell前往討伐癌細胞。1141Please respect copyright.PENANAn7HWW9Oche
1141Please respect copyright.PENANAO9Y53ffnkv
為此,我們重施應對PD1/PDL1故技,利用抗體阻擋CTLA4,確保CD28及B7持續合併,不斷產生效力高強的T cell。1141Please respect copyright.PENANARyvUw0u6xK
1141Please respect copyright.PENANAj65qsGDF74
1141Please respect copyright.PENANAEENCOomWjx
(圖5)簡略的總結來說,為了確保有足夠的T cell消滅癌細胞,我們不惜採用阻擋CTLA4的抗體,號令身體持續產生效力高強的T cell。1141Please respect copyright.PENANANcJ0iHuI5L
而另一邊廂,我們亦同時利用阻擋PD1/PDL1的抗體,確保T cell能夠順利把癌細胞辨認成為外來物,將其制裁。1141Please respect copyright.PENANAddlD26I7Xa
1141Please respect copyright.PENANALXJXpAeZSt
這CTLA4抗體及PD1/PDL1抗體的雙管齊下療法,將能大大提升免疫治療的效率。1141Please respect copyright.PENANAUprR9PjwXF
1141Please respect copyright.PENANATRbDpE0O22
但是,並不是所有病人也能依靠這方法而得益,原因是T cell沒法能夠順利抵達癌細胞的位置以及滲入癌細胞的內部作有效的消滅。1141Please respect copyright.PENANAYEW5hkehkM
1141Please respect copyright.PENANAG1Y7ELFA4G
這一方面,我們將會在下一篇免疫治療的最終章再作探討。1141Please respect copyright.PENANAeGxmAatfBd
1141Please respect copyright.PENANAS2ClK1AwAK
1141Please respect copyright.PENANAbQfuzk4G8Q
如果想我快啲出文的話,請入去Penana網站科普專欄–薯不揀單俾一個like以及Bookmark,這對我非常之重要。1141Please respect copyright.PENANAFMv4Aidsg8
1141Please respect copyright.PENANAIg3dxVkOC6
Link: https://www.penana.com/story/66244/%E7%A7%91%E6%99%AE%E5%B0%88%E6%AC%84-%E8%96%AF%E4%B8%8D%E6%8F%80%E5%96%AE/toc1141Please respect copyright.PENANA5CrAbwbcwX
1141Please respect copyright.PENANAXY2lDQQbDT
同時亦可以在Penana網站裡按「買一嚿/半嚿薯仔」,以課金的方式推動我繼續搜羅資料寫文,多謝。1141Please respect copyright.PENANAFiIO2DQkVL
1141Please respect copyright.PENANAYLxNzGSeOO
Link:1141Please respect copyright.PENANAH7fSYROa6U
https://www.penana.com/user/27349/%E8%96%AF%E4%BB%94%E8%81%9E%E8%8C%B1%E8%8E%89/portfolio1141Please respect copyright.PENANAjAGYjmxjui
1141Please respect copyright.PENANAvPCPc3FjyP
1141Please respect copyright.PENANAOdIfJNBbVd
有興趣接收科普資訊的話,歡迎follow IG: potatopigtongue。1141Please respect copyright.PENANAjimn88xYkm
arrow_back
科普專欄–薯不揀單
more_vert
-
info_outline Info
-
toc Table of Contents
-
share Share
-
format_color_text Display Settings
-
exposure_plus_1 Recommend
-
Sponsor
-
report_problem Report
-
account_circle Login
Search stories, writers or societies
Continue ReadingClear All
What Others Are ReadingRefresh
X
Never miss what's happening on Penana!
科普專欄–薯不揀單
Author:
薯仔聞茱莉
ISSUE #31
深入淺出–以免疫治療(Immunotherapy)手段醫治癌細胞(二)
LIKES 2
READS 1137
BOOKMARKS 148
campaign
Request update 0
Sponsor
Login with Facebook
or Sign up/Login to comment or bookmark!
Click to load the next chapter
X
After each update request, the author will receive a notification!
smartphone100 → Request update
X
Sponsor again
Click to login
Login first to show your name as a sponsor.
Thank you for supporting the story! :)
Please Login first.
×
Write down what you like about the story
×
Reading Theme:
Font Size:
Line Spacing:
Paragraph Spacing:
Load the next issue automatically
Reset to default
×
People Who Like This